BioSig Technologies, Inc. announces a proposed public offering of common stock to purchase gold bullion and for working capital.
The offering is subject to market conditions and will be managed by Clear Street and Needham & Company.
The offering is made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC on December 17, 2024.
Proposed Public Offering
BioSig intends to offer shares of common stock to purchase gold bullion and for working capital.
Underwriters
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Registration Statement
The offering is being made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC on December 17, 2024.
- The public offering will provide BioSig with funds to purchase gold bullion and support its general corporate purposes.
- The joint book-running managers will oversee the process of the offering, ensuring compliance with market regulations.
BioSig Technologies Inc. aims to utilize the net proceeds from the offering strategically for long-term growth and operational needs.